Dr. Vincent Pompili is a Professor of Medicine and the Director of Interventional Cardiovascular Medicine at The Ohio State University Wexner Medical Center. He also serves as the Director of Cardiovascular Cell-Based Therapies at The Davis Heart and Lung Research Institute at Ohio State. Over the past decade, Dr. Pompili has been one the pioneers in the arena of studying the use of adult, non-embryonic, stem cell therapies in cardiovascular disease. He launched one of the first US-based, FDA approved trials using bone marrow derived stem cells to treat patients with advanced heart disease. He is also the founder and Chief Medical Officer of Arteriocyte, Inc, a company focused on advancing cell therapies for tissue repair and cardiac disease.
Dr. Pompili lives in Upper Arlington, Ohio with his wife Suzanne and two daughters. He is a member of Saint Agatha Catholic Church and serves on the Board of Directors of Catholic Youth Summer Camp. He holds a great passion in sharing the truths, successes and challenges in the use of adult, non-embryonic stem cell therapy.